While the enrichment of ECM-related pathways is in line with the known roles of THBS2, FN1, COL1A1, and COL5A1 in extracellular matrix remodelling and tumour progression, the concurrent upregulation of mTOR signalling presents an intriguing finding. The gene discussed is COL5A1; the disease is neoplasm.